Programmed Death-Ligand 1 (PD-L1) Metabolic Modulation Provides Mechanistic and Therapeutic Insight

被引：0
作者：
Palermo, A. [1 ]
Spangenberg, S. [2 ]
Guijas, C. [1 ]
Lairson, L. [2 ]
Siuzdak, G. [1 ,3 ]
机构：
[1] Scripps Res Inst, Scripps Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Mol & Computat Biol, La Jolla, CA 92037 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2018年 / 29卷 / 26期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P1343
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
[21]   PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER [J].
Gulec, U. Kucukgoz ;
Bagir, E. ;
Paydas, S. ;
Seydaoglu, G. ;
Guzel, A. B. ;
Vardar, M. A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 :1127-1127
[22]   Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor [J].
Valentine Suteau ;
Alexandre Collin ;
Philippe Menei ;
Patrice Rodien ;
Marie-Christine Rousselet ;
Claire Briet .
Cancer Immunology, Immunotherapy, 2020, 69 :2053-2061
[23]   PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER [J].
Gulec, U. Kucukgoz ;
Bagir, E. ;
Paydas, S. ;
Seydaoglu, G. ;
Guzel, A. B. ;
Vardar, M. A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 :220-220
[24]   Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer [J].
Gulec, Umran Kucukgoz ;
Bagir, Emine Kilic ;
Paydas, Semra ;
Guzel, Ahmet Baris ;
Gumurdulu, Derya ;
Vardar, Mehmet Ali .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (02) :377-382
[25]   Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA) [J].
Pedersen, Katrina ;
Smyrk, Thomas C. ;
Harrington, Susan ;
McWilliams, Robert R. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[26]   Programmed Death-Ligand 1 (PD-L1) Expression in Upper Tract Urothelial Carcinoma [J].
Skala, Stephanie ;
Liu, Tzu-Ying ;
MUdager, Aaron ;
Weizei, Alon Z. ;
Montgomery, Jeffrey S. ;
Palapattu, Ganesh S. ;
Siddiqui, Javed ;
Cao, Xuhong ;
Fields, Kristina ;
Abugharib, Ahmed E. ;
Soliman, Moaaz ;
Hafez, Khaled S. ;
Miller, David ;
Lee, Cheryl T. ;
Alva, Ajjai ;
Chinnaiyan, Arul M. ;
Morgan, Todd M. ;
Sprott, Daniel E. ;
Jiang, Hui ;
Mehra, Rohit .
LABORATORY INVESTIGATION, 2017, 97 :260A-260A
[27]   Pan-cancer analysis of programmed death-ligand 1 (PD-L1) amplifications [J].
Budczies, Jan ;
Bockmayr, Michael ;
Klauschen, Frederick ;
Weichert, Wilko ;
Denkert, Carsten ;
Stenzinger, Albrecht .
CANCER RESEARCH, 2016, 76
[28]   Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor [J].
Suteau, Valentine ;
Collin, Alexandre ;
Menei, Philippe ;
Rodien, Patrice ;
Rousselet, Marie-Christine ;
Briet, Claire .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) :2053-2061
[29]   PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER [J].
Gulec, U. Kucukgoz ;
Bagir, E. ;
Paydas, S. ;
Guzel, A. B. ;
Khatib, G. ;
Seydaoglu, G. ;
Vardar, M. A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 :1126-1126
[30]   Assessment of programmed death-ligand 1 (PD-L1) expression in different breast tumor subtypes [J].
Sobral-Leite, M. ;
de Vijver, K. Van ;
Kersten, K. ;
Peters, D. ;
Kok, M. ;
Broeks, A. ;
De Visser, K. E. ;
Schmidt, M. K. .
EUROPEAN JOURNAL OF CANCER, 2016, 57 :S128-S128
12345